https://ir.codexis.com/
Codexis, Inc. (CDXS)
Codexis is a leading enzyme engineering company powering scalable, sustainable solutions for therapeutic development. We unlock therapeutic possibilities...
codexis inc
https://www.biospace.com/codexis-reports-third-quarter-2020-financial-results
Codexis Reports Third Quarter 2020 Financial Results - BioSpace
Nov 6, 2020 - Higher sequential sales expected again in the fourth quarter, showing growing momentum as we close 2020
third quarter2020 financialcodexisreportsresults
https://www.biospace.com/codexis-inc-arch-pharmalabs-limited-achieve-development-milestone
Codexis, Inc., Arch Pharmalabs Limited Achieve Development Milestone - BioSpace
codexis incdevelopment milestonearchpharmalabslimited
https://investingnews.com/codexis-to-report-third-quarter-2025-financial-results-on-november-6/
Codexis to Report Third Quarter 2025 Financial Results on November 6 | INN
Oct 23, 2025 - Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced...
2025 financial resultsthird quarter
https://www.upguard.com/security-report/codexis
Codexis Security Rating, Vendor Risk Report, and Data Breaches | UpGuard
Compare Codexis's security performance with other companies. Learn about data breaches, cyber attacks, and security incidents involving Codexis.
security ratingvendor riskdata breachescodexisreport
https://www.biospace.com/press-releases/codexis-announces-new-employment-inducement-grants-january-10-2025
Codexis Announces New Employment Inducement Grants - January 10, 2025 - BioSpace
january 10codexisannouncesnewemployment
https://www.fiercebiotech.com/biotech/crosswalk-picks-fabry-pompe-compounds-abandoned-takeda-codexis-collab
Crosswalk grabs compounds from abandoned Takeda, Codexis collab
Jul 2, 2024 - Crosswalk Therapeutics has strolled over to Codexis to pick up Fabry and Pompe disease compounds that remain from an abandoned Takeda collaboration.
crosswalkgrabscompoundsabandonedtakeda
https://www.macrotrends.net/stocks/charts/CDXS/codexis/cash-flow-statement
Codexis Cash Flow Statement 2011-2026 | CDXS | MacroTrends
Ten years of annual cash flow statements for Codexis (CDXS). The cash flow statement is a summary of the cash inflows and outflows for a business over a given...
cash flow statementcodexis20112026macrotrends
https://www.biospace.com/codexis-to-report-second-quarter-2024-financial-results-on-august-8
Codexis to Report Second Quarter 2024 Financial Results on August 8 - BioSpace
2024 financial resultssecond quarter
https://finviz.com/news/321715/codexis-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-11
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
Stock screener for investors and traders, financial visualizations.
https://www.biospace.com/press-releases/codexis-to-participate-in-td-cowen-45th-annual-health-care-conference
Codexis to Participate in TD Cowen 45th Annual Health Care Conference - BioSpace
to participatetd cowen
https://investingnews.com/codexis-achieves-iso-9001-2015-certification/
Codexis Achieves ISO 9001:2015 Certification | INN
Feb 10, 2026 - Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that it has...
iso 9001 2015codexisachievescertificationinn
https://www.barchart.com/stocks/quotes/CDXS/news
CDXS News for Codexis - Barchart.com
Latest news headlines for Codexis Inc with market analysis and analyst commentary.
newscodexisbarchart
https://www.nasdaq.com/market-activity/stocks/cdxs
Codexis, Inc. Common Stock (CDXS) Stock Price, Quote, News & History | Nasdaq
Discover real-time Codexis, Inc. Common Stock (CDXS) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions....
codexis inccommon stockprice quotenews historynasdaq
https://finviz.com/news/329553/codexis-signs-agreement-to-manufacture-50-g-sirna-using-its-eco-synthesis-manufacturing-platform
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis Manufacturing Platform
Stock screener for investors and traders, financial visualizations.
https://www.biospace.com/codexis-inc-to-announce-fourth-quarter-and-fiscal-year-2012-financial-results-on-february-27-2013
Codexis, Inc. to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on February 27,...
https://www.macrotrends.net/stocks/charts/CDXS/codexis/income-statement
Codexis Income Statement 2011-2026 | CDXS | MacroTrends
Ten years of annual and quarterly income statements for Codexis (CDXS). The income statement summarizes the revenues, expenses and profit generated by a...
income statementcodexis20112026macrotrends
https://www.prnewswire.com/news-releases/dsm-and-codexis-sign-enzyme-supply-agreement-113344459.html
DSM and Codexis Sign Enzyme Supply Agreement
/PRNewswire/ -- DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, and Codexis, Inc. (Nasdaq:CDXS) today announce signing of...
dsmcodexissignenzymesupply
https://www.sofi.com/invest/stock/CDXS/
Buy Codexis Stock - CDXS Stock Price, Quote & News | SoFi
See real time price charts for CDXS stock, historical data, and recent news. Buy CDXS stock online with no commission fees.
price quotebuycodexisstocknews